ag 1879 has been researched along with tretinoin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, R; Johnson, DE; Jones, JE; Kropf, PL; Wang, L | 1 |
| Congleton, J; MacDonald, R; Yen, A | 1 |
| Bunaciu, RP; Congleton, J; Jensen, HA; Styskal, LE; Tasseff, R; Varner, JD; Yen, A | 1 |
| Congleton, J; MacDonald, R; Malavasi, F; Shen, M; Yen, A | 1 |
| Cheong, HJ; Jung, YS; Kim, KH; Kim, SJ; Lee, N; Park, HS; Won, JH | 1 |
| Bunaciu, RP; Jensen, HA; Varner, JD; Yen, A | 1 |
6 other study(ies) available for ag 1879 and tretinoin
| Article | Year |
|---|---|
Src family kinase gene targets during myeloid differentiation: identification of the EGR-1 gene as a direct target.
Topics: Antineoplastic Agents; Cell Differentiation; Early Growth Response Protein 1; Gene Expression Profiling; Humans; Leukemia, Promyelocytic, Acute; Oligonucleotide Array Sequence Analysis; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; src-Family Kinases; Tretinoin; Tumor Cells, Cultured | 2009 |
Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells.
Topics: Antineoplastic Agents; Blotting, Western; Cell Cycle; Cell Differentiation; Dasatinib; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; Humans; Immunoprecipitation; Leukemia, Myeloid; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Protein Kinases; Proto-Oncogene Proteins c-raf; Pyrimidines; RNA, Small Interfering; Signal Transduction; src-Family Kinases; Thiazoles; Tretinoin; Tumor Cells, Cultured | 2012 |
The Src-family kinase inhibitor PP2 rescues inducible differentiation events in emergent retinoic acid-resistant myeloblastic leukemia cells.
Topics: ADP-ribosyl Cyclase 1; Antineoplastic Agents; CD11b Antigen; Cell Differentiation; Drug Resistance, Neoplasm; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; Leukemia, Myeloid; Membrane Glycoproteins; NADPH Oxidases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-cbl; Proto-Oncogene Proteins c-vav; Pyrimidines; Resting Phase, Cell Cycle; src-Family Kinases; Tretinoin | 2013 |
Phosphorylation of c-Cbl and p85 PI3K driven by all-trans retinoic acid and CD38 depends on Lyn kinase activity.
Topics: Adaptor Proteins, Signal Transducing; ADP-ribosyl Cyclase 1; Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Class Ia Phosphatidylinositol 3-Kinase; Dasatinib; HL-60 Cells; Humans; Leukemia, Myeloid; Membrane Glycoproteins; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Protein Binding; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-cbl; Proto-Oncogene Proteins c-vav; Pyrimidines; src-Family Kinases; Thiazoles; Tretinoin | 2014 |
Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; CD11b Antigen; Cell Differentiation; Cell Line, Tumor; Drug Synergism; Humans; Leukemia, Promyelocytic, Acute; Oxides; Pyrimidines; Tretinoin; Up-Regulation | 2014 |
GW5074 and PP2 kinase inhibitors implicate nontraditional c-Raf and Lyn function as drivers of retinoic acid-induced maturation.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; CD11b Antigen; Cell Differentiation; Drug Resistance, Neoplasm; G1 Phase Cell Cycle Checkpoints; HL-60 Cells; Humans; Indoles; Leukemia, Promyelocytic, Acute; Molecular Targeted Therapy; Phenols; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-raf; Pyrimidines; Signal Transduction; src-Family Kinases; Time Factors; Tretinoin | 2015 |